Prospective Exploratory Study on rTMS for Migraine Under the Guidance of MEG

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 6, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Migraine Disorders, BrainrTMS Stimulation
Interventions
DEVICE

rTMS

(1) The patient undergoes pseudo stimulus intervention in the first week and real stimulus intervention afterwards, which is blind to the patient. (2) Starting from the second week, true stimulation intervention will be conducted for 4 weeks, with each patient making an appointment for 1 month. On Day 7 after the patient intervention, Day 14, Day 30, Day 60, Day 90, Day 180 scales were used to evaluate follow-up.

DRUG

Sibelium

Sibelium 10mg is taken orally every night for 4 weeks each course of treatment. Patients were evaluated and followed up with a scale based on medication intervention, including Day 7, Day 14, Day 30, Day 60, Day 90, and Day 180

Trial Locations (1)

Unknown

RECRUITING

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER